Result of intravitreal aflibercept injection for myopic choroidal neovascularization
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Result of intravitreal aflibercept injection for myopic choroidal neovascularization ; volume:21 ; number:1 ; day:22 ; month:9 ; year:2021 ; pages:1-10 ; date:12.2021
BMC ophthalmology ; 21, Heft 1 (22.9.2021), 1-10, 12.2021
- Urheber
-
Chen, Shih-Lin
Tang, Pei-Ling
Wu, Tsung-Tien
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-021-02088-x
- URN
-
urn:nbn:de:101:1-2021121320504727086793
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Shih-Lin
- Tang, Pei-Ling
- Wu, Tsung-Tien
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Progression of macular retinoschisis following intravitreal aflibercept injection for myopic macular neovascularization—a case report and review of literature
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
Treatment of myopic choroidal neovascularization: a network meta-analysis and review
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Progression of macular retinoschisis following intravitreal aflibercept injection for myopic macular neovascularization—a case report and review of literature
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
Treatment of myopic choroidal neovascularization: a network meta-analysis and review
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases
Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patients
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Progression of macular retinoschisis following intravitreal aflibercept injection for myopic macular neovascularization—a case report and review of literature
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
Treatment of myopic choroidal neovascularization: a network meta-analysis and review